Journal of Ophthalmology / 2019 / Article / Tab 2

Research Article

Clinical Features of Combined Central Retinal Artery and Vein Occlusion

Table 2

BCVA at presentation, 2 to 3 weeks after presentation, and at last follow-up.

BCVAAt presentationTwo to 3 weeks after presentationLast follow-up

≥20/604 (12.1%)7 (21.9%)6 (23.1%)
20/200–20/603 (9.1%)6 (18.8%)1 (3.8%)
20/400–20/20004 (12.5%)4 (15.4%)
20/2000–20/40011 (33.3%)11 (33.3%)9 (34.6%)
FC, LP, or NLP15 (45.5%)4 (12.5%)6 (23.1%)
Total (eyes)333226

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.